Sai; Tao

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sai; Tao.The latest application filed is for "antibodies against 4g7-derived chimeric antigen receptors".

Company Profile

7.13.15

Sai; Tao - Foster City CA
Sai; Tao - South San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chimeric antigen receptors targeting CD70 Grant 11,396,551 - Srivatsa Srinivasan , et al. July 26, 2	2022-07-26
Antibodies specific for CD70 and their uses Grant 11,377,500 - Panowski , et al. July 5, 2	2022-07-05
Antibodies Against 4g7-derived Chimeric Antigen Receptors App 20200331998 - PERTEL; Thomas Charles ; et al.	2020-10-22
ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF App 20190375856 - KELLEY; Robert F. ; et al.	2019-12-12
Anti-HtrA1 antibodies and methods of use thereof Grant 10,421,822 - Kelley , et al. Sept	2019-09-24
Anti-HtrA1 antibodies and methods of use thereof Grant 10,421,821 - Kelley , et al. Sept	2019-09-24
Antibodies Specific For Cd70 And Their Uses App 20190233529 - Panowski; Siler ; et al.	2019-08-01
Chimeric Antigen Receptors Targeting Cd70 App 20190233528 - Srivatsa Srinivasan; Surabhi ; et al.	2019-08-01
High affinity antibodies that neutralize Staphylococcus enterotoxin B Grant 10,364,284 - Sass , et al.	2019-07-30
ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF App 20190048097 - Kelley; Robert F. ; et al.	2019-02-14
High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B App 20180094048 - Sass; Philip M. ; et al.	2018-04-05
High affinity antibodies that neutralize Staphylococcus enterotoxin B Grant 9,868,780 - Sass , et al. January 16, 2	2018-01-16
ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF App 20170145113 - KELLEY; Robert F. ; et al.	2017-05-25
High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B App 20170121396 - Sass; Philip M. ; et al.	2017-05-04
Use of anti-CD83 agonist antibodies for treating autoimmune diseases Grant 9,562,097 - Diehl , et al. February 7, 2	2017-02-07
High affinity antibodies that neutralize Staphylococcus enterotoxin B Grant 9,359,428 - Sass , et al. June 7, 2	2016-06-07
High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B App 20150050276 - Sass; Philip M. ; et al.	2015-02-19
High affinity antibodies that neutralize Staphylococcus enterotoxin B Grant 8,895,704 - Sass , et al. November 25, 2	2014-11-25
High affinity antibodies that neutralize Staphylococcus enterotoxin B Grant 8,889,846 - Sass , et al. November 18, 2	2014-11-18
Use Of Anti-cd83 Agonist Antibodies For Treating Autoimmune Diseases App 20140286950 - Diehl; Lauri ; et al.	2014-09-25
High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B App 20140072553 - Sass; Philip M. ; et al.	2014-03-13
High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B App 20130183314 - Sass; Philip M. ; et al.	2013-07-18
High affinity antibodies that neutralize Staphylococcus enterotoxin B Grant 8,236,932 - Sass , et al. August 7, 2	2012-08-07
High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B App 20120171223 - Sass; Philip M. ; et al.	2012-07-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.